Argus analyst David Toung upgraded Solventum (SOLV) to Buy from Hold with a $90 price target. The company has registered sequential topline growth over the past few quarters and showed earnings power with its Q1 results, the analyst tells investors in a research note. While there is still considerable work to restructure and reposition the company after its separation from 3M (MMM), Solventum has transformed into a faster-growing and higher-margin business model under the leadership of CEO Bryan Hanson, Argus added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum upgraded to Buy from Hold at Argus
- Hold Rating Maintained for Solventum Corporation Amid Strategic P&F Business Transaction Adjustments
- Solventum Amends Acquisition Deal with Thermo Fisher
- Solventum initiated with a Sector Weight at KeyBanc
- Solventum upgraded to Overweight from Neutral at Piper Sandler